{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:48Z","timestamp":1786982148172,"version":"build-2736575974"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11940-020-0612-z","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T02:02:41Z","timestamp":1580868161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease"],"prefix":"10.1007","volume":"22","author":[{"given":"Luigi","family":"Ferini-Strambi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Casoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Salsone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"issue":"9770","key":"612_CR1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer\u2019s disease. Lancet. 2011;377(9770):1019\u201331.","journal-title":"Lancet."},{"issue":"6","key":"612_CR2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329.","journal-title":"Lancet Neurol"},{"key":"612_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neubiorev.2018.09.027","volume":"97","author":"R Winsky-Sommerer","year":"2019","unstructured":"Winsky-Sommerer R, de Oliveira P, Loomis S, Wafford K, Dijk DJ, Gilmour G. Disturbances of sleep quality, timing and structure and their relationship with other neuropsychiatric symptoms in Alzheimer\u2019s disease and schizophrenia: insights from studies in patient populations and animal models. Neurosci Biobehav Rev. 2019;97:112\u201337.","journal-title":"Neurosci Biobehav Rev"},{"key":"612_CR4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smrv.2017.06.010","volume":"40","author":"L Shi","year":"2018","unstructured":"Shi L, Chen SJ, Ma MY, Bao YP, Han Y, Wang YM, et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev. 2018;40:4\u201316.","journal-title":"Sleep Med Rev"},{"issue":"8","key":"612_CR5","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1093\/brain\/awx148","volume":"140","author":"YS Ju","year":"2017","unstructured":"\u2022\u2022 Ju YS, Ooms SJ, Sutphen C, Macauley SL, Zangrilli MA, Jerome G, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-\u03b2 levels. Brain. 2017;140(8):2104\u201311. This work experimentally demonstrates that slow wave activity disruption increases amyloid-\u03b2 levels.","journal-title":"Brain"},{"issue":"7","key":"612_CR6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn.4035","volume":"18","author":"BA Mander","year":"2015","unstructured":"\u2022\u2022 Mander BA, Marks SM, Vogel JW, Rao V, Lu B, Saletin JM, et al. \u03b2-Amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci. 2015;18(7):1051\u20137. This work describes how sleep disruption is able to influence hippocampus-dependent cognitive deterioration throughout \u03b2-amyloid pathology in the elderly.","journal-title":"Nat Neurosci"},{"issue":"12","key":"612_CR7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1212\/WNL.0000000000004373","volume":"89","author":"MP Pase","year":"2017","unstructured":"\u2022 Pase MP, Himali JJ, Grima NA, Beiser AS, Satizabal CL, et al. Sleep architecture and the risk of incident dementia in the community. Neurology. 2017;89(12):1244\u201350. This study identifies REM sleep as a predictor of the onset of clinical dementia.","journal-title":"Neurology"},{"issue":"12","key":"612_CR8","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jocn.2014.05.041","volume":"21","author":"FF de Oliveira","year":"2014","unstructured":"de Oliveira FF, Bertolucci PH, Chen ES, Smith MA. Assessment of sleep satisfaction in patients with dementia due to Alzheimer\u2019s disease. J Clin Neurosci. 2014;21(12):2112\u201327.","journal-title":"J Clin Neurosci"},{"key":"612_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.smrv.2014.03.007","volume":"19","author":"L Peter-Derex","year":"2015","unstructured":"Peter-Derex L, Yammine P, Bastuji H, Croisile B. Sleep and Alzheimer\u2019s disease. Sleep Med Rev. 2015;19:29\u201338.","journal-title":"Sleep Med Rev"},{"issue":"6","key":"612_CR10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/JGP.0b013e318252e3ff","volume":"20","author":"EI Most","year":"2012","unstructured":"Most EI, Aboudan S, Scheltens P, Van Someren EJ. Discrepancy between subjective and objective sleep disturbances in early- and moderate-stage Alzheimer disease. Am J Geriatr Psychiatry. 2012;20(6):460\u20137.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"612_CR11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jalz.2016.11.006","volume":"13","author":"M Lauriola","year":"2017","unstructured":"Lauriola M, Esposito R, Delli Pizzi S, de Zambotti M, Londrillo F, et al. Sleep changes without medial temporal lobe or brain cortical changes in community-dwelling individuals with subjective cognitive decline. Alzheimers Dement. 2017;13(7):783\u201391.","journal-title":"Alzheimers Dement"},{"key":"612_CR12","doi-asserted-by":"crossref","unstructured":"De Gennaro L, Gorgoni M, Reda F, Lauri G, Truglia I, Cordone S,et al., The fall of sleep K-complex in Alzheimer disease. Sci Rep. 2017; 7:39688. This study underlines the role of K-complex density in differentiating between AD patients and healthy individuals.","DOI":"10.1038\/srep39688"},{"key":"612_CR13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1176\/appi.ajp.158.5.704","volume":"158","author":"L Volicer","year":"2001","unstructured":"Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer\u2019s disease. Am J Psychiatry. 2001;158:704\u201311.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"612_CR14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(18)30461-7","volume":"18","author":"Y Leng","year":"2019","unstructured":"Leng Y, Musiek ES, Hu K, Cappuccio FP, Yaffe K. Association between circadian rhythms and neurodegenerative diseases. Lancet Neurol. 2019;18(3):307\u201318.","journal-title":"Lancet Neurol"},{"key":"612_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00005072-199901000-00004","volume":"58","author":"EG Stopa","year":"1999","unstructured":"Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol. 1999;58:29\u201339.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"612_CR16","doi-asserted-by":"crossref","first-page":"14575","DOI":"10.3390\/ijms140714575","volume":"14","author":"L Lin","year":"2013","unstructured":"Lin L, Huang QX, Yang SS, Chu J, Wang JZ, Tian Q. Melatonin in Alzheimer\u2019s disease. Int J Mol Sci. 2013;14(7):14575\u201393.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"612_CR17","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3233\/JAD-170900","volume":"62","author":"AA Balmik","year":"2018","unstructured":"Balmik AA, Chinnathambi S. Multi-faceted role of melatonin in neuroprotection and amelioration of tau aggregates in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;62(4):1481\u201393.","journal-title":"J Alzheimers Dis"},{"key":"612_CR18","first-page":"CD009178","volume":"3","author":"J McCleery","year":"2014","unstructured":"\u2022 McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in Alzheimer's disease. Cochrane Database Syst Rev. 2014;3:CD009178. This review critically discusses the existing literature on the pharmacological strategies to treat sleep disorders in Alzheimer disease.","journal-title":"Cochrane Database Syst Rev"},{"key":"612_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/psyg.12191","volume":"17","author":"FM Scoralick","year":"2017","unstructured":"Scoralick FM, Louzada LL, Quintas JL, Naves JO, Camargos EF, Nobrega OT. Mirtazapine does not improve sleep disorders in Alzheimer\u2019s disease: results from a double-blind, placebo-controlled pilot study. Psychogeriatrics. 2017;17:89\u201396.","journal-title":"Psychogeriatrics"},{"issue":"2","key":"612_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0004867417747402","volume":"52","author":"A Hamuro","year":"2018","unstructured":"\u2022 Hamuro A, Honda M, Wakaura Y. Suvorexant for the treatment of insomnia in patients with Alzheimer\u2019s disease. Aust N Z J psychiatry. 2018;52(2):207\u20138. This study shows the adequate efficacy of suvorexant in the treatment of insomnia in Alzheimer disease with improvement of cognitive performance.","journal-title":"Aust N Z J psychiatry"},{"key":"612_CR21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3233\/JAD-181145","volume":"67","author":"AL La","year":"2019","unstructured":"\u2022\u2022 La AL, Walsh CM, Neylan TC, Vossel KA, Yaffe K, et al. Long-Term trazodone use and cognition: a potential therapeutic role for slow-wave sleep enhancers. J Alzheimers Dis. 2019;67:911\u201321. This study demonstrates, for the first time, the potential beneficial effects of long-term trazodone use on sleep parameters and decline in cognition.","journal-title":"J Alzheimers Dis"},{"key":"612_CR22","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","volume":"345","author":"S de Billioti Gage","year":"2012","unstructured":"de Billioti Gage S, B\u00e9gaud B, Bazin F, Verdoux H, Dartigues JF, P\u00e9r\u00e8s K, et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ. 2012;345:e6231.","journal-title":"BMJ"},{"issue":"9","key":"612_CR23","volume":"13","author":"J Lee","year":"2018","unstructured":"Lee J, Jung SJ, Choi JW, Shin A, Lee YJ. Use of sedative-hypnotics and the risk of Alzheimer\u2019s dementia: a retrospective cohort study. PLoS One. 2018;13(9):e0204413.","journal-title":"PLoS One"},{"issue":"11","key":"612_CR24","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/jgs.15018","volume":"65","author":"HT Cheng","year":"2017","unstructured":"Cheng HT, Lin FJ, Erickson SR, Hong JL, Wu CH. The association between the use of zolpidem and the risk of Alzheimer\u2019s disease among older people. J Am Geriatr Soc. 2017;65(11):2488\u201395.","journal-title":"J Am Geriatr Soc"},{"key":"612_CR25","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","volume":"352","author":"SL Gray","year":"2016","unstructured":"Gray SL, Dublin S, Yu O, Walker R, Anderson M, Hubbard RA, et al. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ. 2016 Feb 2;352:i90.","journal-title":"BMJ."},{"issue":"2","key":"612_CR26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.12909","volume":"138","author":"V Tapiainen","year":"2018","unstructured":"Tapiainen V, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM. The risk of Alzheimer\u2019s disease associated with benzodiazepines and related drugs: a nested case-control study. Acta Psychiatr Scand. 2018;138(2):91\u2013100.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"612_CR27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40263-016-0404-x","volume":"31","author":"FA Bi\u00e9try","year":"2017","unstructured":"Bi\u00e9try FA, Pfeil AM, Reich O, Schwenkglenks M, Meier CR. Benzodiazepine use and risk of developing Alzheimer's disease: a case-control study based on Swiss claims data. CNS Drugs. 2017;31(3):245\u201351.","journal-title":"CNS Drugs"},{"issue":"2","key":"612_CR28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0044-100523","volume":"52","author":"P Hessmann","year":"2019","unstructured":"Hessmann P, Dodel R, Baum E, M\u00fcller MJ, Paschke G, Kis B, et al. Prescription of benzodiazepines and related drugs in patients with mild cognitive deficits and Alzheimer\u2019s disease. Pharmacopsychiatry. 2019;52(2):84\u201391.","journal-title":"Pharmacopsychiatry."},{"key":"612_CR29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neuropharm.2018.11.003","volume":"144","author":"V Pilipenko","year":"2019","unstructured":"\u2022\u2022 Pilipenko V, Narbute K, Pupure J, Rumaks J, Jansone B, Klusa V. Neuroprotective action of diazepam at very low and moderate doses in Alzheimer\u2019s disease model rats. Neuropharmacology. 2019;144:319\u201326. This study demonstrates the potential neuroprotective effect of the benzodiazepines in animal AD models.","journal-title":"Neuropharmacology"},{"issue":"1","key":"612_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(92)90322-X","volume":"141","author":"H Tohgi","year":"1992","unstructured":"Tohgi H, Abe T, Takahashi S, Kimura M, Takahashi J, Kikuchi T. Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia. Neurosci Lett. 1992;141(1):9\u201312.","journal-title":"Neurosci Lett"},{"issue":"4","key":"612_CR31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-3223(97)00510-6","volume":"45","author":"K Mishima","year":"1999","unstructured":"Mishima K, Tozawa T, Satoh K, Matsumoto Y, Hishikawa Y, Okawa M. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer\u2019s type with disturbed sleep-waking. Biol Psychiatry. 1999;45(4):417\u201321.","journal-title":"Biol Psychiatry"},{"key":"612_CR32","first-page":"947","volume":"9","author":"AG Wade","year":"2014","unstructured":"\u2022\u2022 Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, et al. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer\u2019s disease: a 6-month, randomized, placebo-controlled, multicenter trial. Clin Interv Aging. 2014;9:947. This study shows the beneficial effects of long-term add-on prolonged-release melatonin use on sleep and cognition.","journal-title":"Clin Interv Aging"},{"key":"612_CR33","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jagp.2013.12.174","volume":"22","author":"EF Camargos","year":"2014","unstructured":"Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, Nobrega OT. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Am J Geriatr Psychiatry. 2014;22:1565\u201374.","journal-title":"Am J Geriatr Psychiatry"},{"key":"612_CR34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/JCP.0000000000000237","volume":"35","author":"EF Camargos","year":"2015","unstructured":"Camargos EF, Quintas JL, Louzada LL, Naves JO, Furioso AC, Nobrega OT. Trazodone and cognitive performance in Alzheimer disease. J Clin Psychopharmacol. 2015;35:88\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"612_CR35","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.5664\/jcsm.5.2S.S27","volume":"5","author":"JK Walsh","year":"2009","unstructured":"Walsh JK. Enhancement of slow wave sleep: implications for insomnia. J Clin Sleep Med. 2009;5:S27\u201332.","journal-title":"J Clin Sleep Med"},{"key":"612_CR36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1272\/jnms.69.333","volume":"69","author":"H Suzuki","year":"2002","unstructured":"Suzuki H, Yamadera H, Nakamura S, Endo S. Effects of trazodone and imipramine on the biological rhythm: an analysis of sleep EEG and body core temperature. J Nippon Med Sch. 2002;69:333\u201341.","journal-title":"J Nippon Med Sch"},{"key":"612_CR37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00172629","volume":"95","author":"J Mouret","year":"1988","unstructured":"Mouret J, Lemoine P, Minuit MP, Benkelfat C, Renardet M. Effects of trazodone on the sleep of depressed subjects-a polygraphic study. Psychopharmacology. 1988;95:37\u201343.","journal-title":"Psychopharmacology"},{"key":"612_CR38","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1084\/jem.20141788","volume":"211","author":"JH Roh","year":"2014","unstructured":"Roh JH, Jiang H, Finn MB, Stewart FR, Mahan TE, Cirrito JR. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer\u2019s disease. J Exp Med. 2014;211:2487\u201396.","journal-title":"J Exp Med"},{"key":"612_CR39","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/brain\/awx074","volume":"140","author":"M Halliday","year":"2017","unstructured":"Halliday M, Radford H, Zents KAM, Molloy C, Moreno JA, Verity NC, et al. Repurposed drugs targeting eIF2alpha-P-mediated translational repression prevent neurodegeneration in mice. Brain. 2017;140:1768\u201383.","journal-title":"Brain"},{"key":"612_CR40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature11058","volume":"485","author":"JA Moreno","year":"2012","unstructured":"Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, Martin MG, et al. Sustained translational repression by eIF2alpha-P mediatesnprion neurodegeneration. Nature. 2012;485:507\u201311.","journal-title":"Nature"},{"key":"612_CR41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/path.3969","volume":"226","author":"DA Nijholt","year":"2012","unstructured":"Nijholt DA, van Haastert ES, Rozemuller AJ, Scheper W, Hoozemans JJ. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies. J Pathol. 2012;226:693\u2013702.","journal-title":"J Pathol"},{"key":"612_CR42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2051-5960-1-31","volume":"1","author":"LD Stutzbach","year":"2013","unstructured":"Stutzbach LD, Xie SX, Naj AC, Albin R, Gilman S, Group PSPGS, et al. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer\u2019s disease. Acta Neuropathol Commun. 2013;1:31.","journal-title":"Acta Neuropathol Commun"},{"key":"612_CR43","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1471-4159.2004.02952.x","volume":"92","author":"N Naidoo","year":"2005","unstructured":"Naidoo N, Giang W, Galante RJ, Pack AI. Sleep deprivation induces the unfolded protein response in mouse cerebral cortex. J Neurochem. 2005;92:1150\u20137.","journal-title":"J Neurochem"},{"key":"612_CR44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-3223(94)00135-P","volume":"37","author":"AL Sharpley","year":"1995","unstructured":"Sharpley AL, Cowen PJ. Effect of pharmachologic treatments on the sleep of depressed patients. Biol Psychiatry. 1995;37:85\u201398.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"612_CR45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000118285","volume":"15","author":"Herbert Moskowitz","year":"1986","unstructured":"Moskowitz H, Burns MM. Cognitive performance in geriatric subjects after acute treatment with antidepressants. Neuropsychobiology. 15(Suppl 1):38\u201343.","journal-title":"Neuropsychobiology"},{"key":"612_CR46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5664\/jcsm.5100","volume":"11","author":"RR Auger","year":"2015","unstructured":"Auger RR, Burgess HJ, Emens JS, Deriy LV, Thomas SM, Sharkey KM. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleepwake disorders: advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake phase disorder (DSWPD), non-24-hour sleep-wake rhythm disorder (N24SWD), and irregular sleepwake rhythm disorder (ISWRD). An update for 2015: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2015;11:1199\u201336.","journal-title":"J Clin Sleep Med"},{"issue":"10","key":"612_CR47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00023210-200115100-00004","volume":"15","author":"MV Vitiello","year":"2001","unstructured":"Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer\u2019s disease: epidemiology, pathophysiology and treatment. CNS Drugs. 2001;15(10):777\u201396.","journal-title":"CNS Drugs"},{"issue":"5","key":"612_CR48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopsych.2012.11.021","volume":"74","author":"AN Coogan","year":"2013","unstructured":"Coogan AN, Schutova B, Husung S, et al. The circadian system in Alzheimer\u2019s disease: disturbances, mechanisms, and opportunities. Biol Psychiatry. 2013;74(5):333\u20139.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"612_CR49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40520-015-0431-3","volume":"28","author":"G Gnanasekaran","year":"2016","unstructured":"Gnanasekaran G. \u201cSundowning\u201d as a biological phenomenon: current understandings and future directions: an update. Aging Clin Exp Res. 2016;28(3):383\u201392.","journal-title":"Aging Clin Exp Res"},{"issue":"Suppl 1A","key":"612_CR50","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1098-3597(04)90014-2","volume":"6","author":"DL Bliwise","year":"2004","unstructured":"Bliwise DL. Sleep disorders in Alzheimer\u2019s disease and other dementias. Clin Cornerstone. 2004;6(Suppl 1A):S16\u201328.","journal-title":"Clin Cornerstone"},{"key":"612_CR51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/(SICI)1099-1166(1998100)13:10<682::AID-GPS847>3.0.CO;2-Y","volume":"13","author":"T Hope","year":"1998","unstructured":"Hope T, Keene J, Gedling K, Fairburn CG, Jacoby R. Predictors of institutionalization for people with dementia living at home with a carer. International Journal of Geriatric Psychiatry. 1998;13:682\u201390.","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"3","key":"612_CR52","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.3390\/medsci6030052","volume":"6","author":"J Homolak","year":"2018","unstructured":"\u2022\u2022 Homolak J, Mudrov\u010di\u0107 M, Vuki\u0107 B, Toljan K. Circadian rhythm and Alzheimer\u2019s disease. Med Sci (Basel). 2018;6(3):E52. https:\/\/doi.org\/10.3390\/medsci6030052. This article focuses on the bi-directional relationship between the neurodegenerative process of Alzheimer disease and the disruption of circadian rhythm.","journal-title":"Med Sci (Basel)"},{"key":"612_CR53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.smrv.2017.07.005","volume":"40","author":"J Van Erum","year":"2018","unstructured":"Van Erum J, Van Dam D, De Deyn PP. Sleep and Alzheimer\u2019s disease: a pivotal role for the suprachiasmatic nucleus. Sleep Med Rev. 2018;40:17\u201327.","journal-title":"Sleep Med Rev"},{"issue":"8","key":"612_CR54","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1007\/s12035-016-0165-z","volume":"54","author":"Q Song","year":"2017","unstructured":"Song Q, Feng G, Huang Z, Chen X, Chen Z, Ping Y. Aberrant axonal arborization of PDF neurons induced by Abeta42-mediated JNK activation underlies sleep disturbance in an Alzheimer\u2019s model. Mol Neurobiol. 2017;54(8):6317\u201328.","journal-title":"Mol Neurobiol"},{"issue":"5955","key":"612_CR55","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"JE Kang","year":"2009","unstructured":"Kang JE, Lim MM, Bateman RJ, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cyclee. Science. 2009;326(5955):1005\u20137.","journal-title":"Science."},{"issue":"2","key":"612_CR56","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0006-8993(89)90653-7","volume":"501","author":"JC Blanks","year":"1989","unstructured":"Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer\u2019s disease. Brain Res. 1989;501(2):364\u201372.","journal-title":"Brain Res"},{"issue":"1","key":"612_CR57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0161-6420(90)32621-0","volume":"97","author":"AA Sadun","year":"1990","unstructured":"Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer\u2019s disease. Ophthalmology. 1990;97(1):9\u201317.","journal-title":"Ophthalmology."},{"issue":"8","key":"612_CR58","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer\u2019s disease. N Engl J Med. 1986;315(8):485\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"612_CR59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol. 2016;79(1):90\u2013109.","journal-title":"Ann Neurol"},{"issue":"5557","key":"612_CR60","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1126\/science.1067262","volume":"295","author":"DM Berson","year":"2002","unstructured":"Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(5557):1070\u20133.","journal-title":"Science."},{"issue":"5557","key":"612_CR61","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1069609","volume":"295","author":"S Hattar","year":"2002","unstructured":"Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science. 2002;295(5557):1065\u201370.","journal-title":"Science."},{"key":"612_CR62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0006-8993(84)90252-X","volume":"302","author":"AA Sadun","year":"1984","unstructured":"Sadun AA, Schaechter JD, Smith LE. A retinohypothalamic pathway in man: light mediation of circadian rhythms. Brain Res. 1984;302:371\u20137.","journal-title":"Brain Res"},{"key":"612_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-27789-7_1","volume":"182","author":"J Hannibal","year":"2006","unstructured":"Hannibal J, Fahrenkrug J. Neuronal input pathways to the brain\u2019s biological clock and their functional significance. Adv Anat Embryol Cell Biol. 2006;182:1\u201371.","journal-title":"Adv Anat Embryol Cell Biol"},{"issue":"2","key":"612_CR64","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1471301211426909","volume":"12","author":"CA Brown","year":"2013","unstructured":"\u2022 Brown CA, Berry R, Tan MC, Khoshia A, Turlapati L, Swedlove F. A critique of the evidence base for non-pharmacological sleep interventions for persons with dementia. Dementia (London). 2013;12(2):210\u201337. This review provides a critical analysis about the literature on non-pharmacological interventions to reduce disordered sleep in persons with dementia.","journal-title":"Dementia (London)"},{"issue":"10","key":"612_CR65","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.buildenv.2011.03.013","volume":"46","author":"MM Sinoo","year":"2001","unstructured":"Sinoo MM, Van Hoof J, Kort HSM. Light conditions for older adults in the nursing home: assessment of environmental illuminances and colour temperature. Build Environ. 2001;46(10):1917\u201327.","journal-title":"Build Environ"},{"issue":"4","key":"612_CR66","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-2012-120484","volume":"31","author":"MG Figueiro","year":"2012","unstructured":"Figueiro MG, Hamner R, Higgins P, Hornick T, Rea MS. Field measurements of light exposures and circadian disruption in two populations of older adults. J Alzheimers Dis. 2012;31(4):711\u20135.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"612_CR67","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1532-5415.1999.tb03833.x","volume":"47","author":"CA Alessi","year":"1999","unstructured":"Alessi CA, Yoon EJ, Schnelle JF, Al-Samarrai NR, Cruise PA. A randomized trial of a combined physical activity and environmental intervention in nursing home residents: do sleep and agitation improve? J Am Geriatr Soc. 1999;47(7):784\u201391.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"612_CR68","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1532-5415.2005.53251.x","volume":"53","author":"CA Alessi","year":"2005","unstructured":"\u2022 Alessi CA, Martin JL, Webber AP, Cynthia Kim E, Harker JO, Josephson KR. Randomized, controlled trial of a nonpharmacological intervention to improve abnormal sleep\/wake patterns in nursing home residents. J Am Geriatr Soc. 2005;53(5):803\u201310. This study showed the importance of non-pharmacological intervention and sleep hygiene techniques to improve the circadian rhythms in nursing homes.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"612_CR69","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1532-5415.2011.03519.x","volume":"59","author":"SM McCurry","year":"2011","unstructured":"McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer\u2019s disease: results of a randomized, controlled trial. J Am Geriatr Soc. 2011;59(8):1393\u2013402.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"612_CR70","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1532-5415.2005.53252.x","volume":"53","author":"SM McCurry","year":"2005","unstructured":"McCurry SM, Gibbons LE, Logsdon RG, Vitiello MV, Teri L. Nighttime insomnia treatment and education for Alzheimer\u2019s disease: a randomized, controlled trial. J Am Geriatr Soc. 2005;53(5):793\u2013802.","journal-title":"J Am Geriatr Soc"},{"issue":"19","key":"612_CR71","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.2012.36918","volume":"308","author":"LN Gitlin","year":"2012","unstructured":"Gitlin LN, Kales HC, Lyketsos CG. Nonpharmacologic management of behavioral symptoms in dementia. JAMA. 2012;308(19):2020\u20139.","journal-title":"JAMA."},{"issue":"9","key":"612_CR72","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11940-016-0424-3","volume":"18","author":"S Ooms","year":"2016","unstructured":"Ooms S, Ju YE. Treatment of sleep disorders in dementia. Curr Treat Options Neurol. 2016;18(9):40.","journal-title":"Curr Treat Options Neurol"},{"issue":"8","key":"612_CR73","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1176\/ajp.149.8.1028","volume":"149","author":"A Satlin","year":"1992","unstructured":"Satlin A, Volicer L, Ross V, Herz L, Campbell S. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer\u2019s disease. Am J Psychiatry. 1992;149(8):1028\u201332.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"612_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1994.tb01477.x","volume":"89","author":"K Mishima","year":"1994","unstructured":"Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand. 1994;89(1):1\u20137.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"612_CR75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002093-199709000-00011","volume":"11","author":"CC Colenda","year":"1997","unstructured":"Colenda CC, Cohen W, McCall WV, Rosenquist PB. Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Dis Assoc Disord. 1997;11(3):175\u20138.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"612_CR76","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0006-3223(97)89928-3","volume":"41","author":"EJ Van Someren","year":"1997","unstructured":"Van Someren EJ, Kessler A, Mirmiran M, Swaab DF. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry. 1997 May 1;41(9):955\u201363.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"612_CR77","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3109\/07420529808993200","volume":"15","author":"K Mishima","year":"1998","unstructured":"Mishima K, Hishikawa Y, Okawa M. Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer\u2019s type. Chronobiol Int. 1998;15(6):647\u201354.","journal-title":"Chronobiol Int"},{"issue":"7","key":"612_CR78","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/(SICI)1099-1166(199907)14:7<520::AID-GPS983>3.0.CO;2-M","volume":"14","author":"CG Lyketsos","year":"1999","unstructured":"Lyketsos CG, Lindell Veiel L, Baker A, Steele C. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int J Geriatr Psychiatry. 1999;14(7):520\u20135.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"612_CR79","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1440-1819.2000.00711.x","volume":"54","author":"H Yamadera","year":"2000","unstructured":"Yamadera H, Ito T, Suzuki H, Asayama K, Ito R, Endo S. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci. 2000;54(3):352\u20133.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"612_CR80","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1440-1819.2001.00860.x","volume":"55","author":"T Ito","year":"2001","unstructured":"Ito T, Yamadera H, Ito R, Suzuki H, Asayama K, Endo S. Effects of vitamin B12 on bright light on cognitive and sleep-wake rhythm in Alzheimer-type dementia. Psychiatry Clin Neurosci. 2001;55(3):281\u20132.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"612_CR81","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1532-5415.2002.50060.x","volume":"50","author":"S Ancoli-Israel","year":"2002","unstructured":"Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MR. Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc. 2002;50(2):282\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"612_CR82","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1207\/S15402010BSM0101_4","volume":"1","author":"S Ancoli-Israel","year":"2003","unstructured":"Ancoli-Israel S, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer\u2019s disease patients. Behav Sleep Med. 2003a;1(1):22\u201336.","journal-title":"Behav Sleep Med"},{"issue":"2","key":"612_CR83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00019442-200303000-00010","volume":"11","author":"SL Ancoli-Israel","year":"2003","unstructured":"Ancoli-Israel SL, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, et al. Levi Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry. 2003b;11(2):194\u2013203.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"612_CR84","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/gps.852","volume":"18","author":"A Fetveit","year":"2003","unstructured":"Fetveit A, Skjerve A, Bjorvatn B. Bright light treatment improves sleep in institutionalized elderly \u2013 an open trial. Int J Geriatr Psychiatry. 2003;18(6):520\u20136.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1\u20132","key":"612_CR85","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0531-5565(02)00164-X","volume":"38","author":"P Fontana Gasio","year":"2003","unstructured":"Fontana Gasio P, Kr\u00e4uchi K, Cajochen C, Ev S, Amrhein I, Pache M, et al. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Exp Gerontol. 2003;38(1\u20132):207\u201326.","journal-title":"Exp Gerontol"},{"issue":"4","key":"612_CR86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1440-1819.2004.01265.x","volume":"58","author":"A Skjerve","year":"2004","unstructured":"Skjerve A, Holsten F, Aarsland D, Bjorvatn B, Nygaard HA, Johansen IM. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia. Psychiatry Clin Neurosci. 2004;58(4):343\u20137.","journal-title":"Psychiatry Clin Neurosci"},{"key":"612_CR87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1532-5415.2007.01543.x","volume":"56","author":"GA Dowling","year":"2008","unstructured":"Dowling GA, Burr RL, Van Someren EJ, et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer\u2019s disease. J Am Geriatr Soc. 2008;56:239\u201346.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"612_CR88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S1041610205001584","volume":"17","author":"GA Dowling","year":"2005","unstructured":"Dowling GA, Hubbard EM, Mastick J, Luxenberg JS, Burr RL, Van Someren EJ. Effect of morning bright light treatment for rest\u2013activity disruption in institutionalized patients with severe Alzheimer\u2019s disease. Int Psychogeriatr. 2005a;17(2):221\u201336.","journal-title":"Int Psychogeriatr"},{"issue":"22","key":"612_CR89","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1001\/jama.299.22.2642","volume":"299","author":"RF Riemersma-van der Lek","year":"2008","unstructured":"Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA. 2008;299(22):2642\u201355.","journal-title":"JAMA."},{"issue":"4","key":"612_CR90","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1017\/S1041610209008886","volume":"21","author":"A Burns","year":"2009","unstructured":"Burns A, Allen H, Tomenson B, Duignan D, Byrne J. Bright light therapy for agitation in dementia: a randomized controlled trial. Int Psychogeriatr. 2009;21(4):711\u201321.","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"612_CR91","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/gps.1352","volume":"20","author":"GA Dowling","year":"2005","unstructured":"Dowling GA, Mastick J, Hubbard EM, Luxenberg JS, Burr RL. Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2005b;20(8):738\u201343.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"612_CR92","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1477153513517255","volume":"47","author":"PD Sloane","year":"2015","unstructured":"Sloane PD, Figueiro M, Garg S, Cohen LW, Reed D, Williams CS, et al. Effect of home-based light treatment on persons with dementia and their caregivers. Light Res Technol. 2015;47(2):161\u201376.","journal-title":"Light Res Technol"},{"issue":"5","key":"612_CR93","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/psyg.12233","volume":"17","author":"H Sekiguchi","year":"2017","unstructured":"Sekiguchi H, Iritani S, Fujita K. Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer\u2019s type dementia: a case series. Psychogeriatrics. 2017;17(5):275\u201381.","journal-title":"Psychogeriatrics."},{"key":"612_CR94","doi-asserted-by":"crossref","unstructured":"Forbes D, Blake CM, Thiessen EJ, Peacock S, Hawranik P. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev. 2014;(2):CD003946. This review concluded that insufficient evidence justified bright light therapy in dementia patients.","DOI":"10.1002\/14651858.CD003946.pub4"},{"key":"612_CR95","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.smrv.2015.08.009","volume":"29","author":"A van Maanen","year":"2016","unstructured":"\u2022\u2022 van Maanen A, Meijer AM, van der Heijden KB, Oort FJ. The effects of light therapy on sleep problems: a systematic review and meta-analysis. Sleep Med Rev. 2016;29:52\u201362. This recent meta-analysis review the effect of light therapy on sleep problems in general and on specific types of sleep problems, showing significant efficacy of bright light therapy for sleep problems in general, particularly for circadian outcomes and insomnia symptoms.","journal-title":"Sleep Med Rev"},{"issue":"4","key":"612_CR96","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1272\/jnms.70.334","volume":"70","author":"Kentaro Asayama","year":"2003","unstructured":"Asayama K,Yamadera H, Ito T, Suzuki H, KudoY, Endo S. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2003; 70:334\u2013341.","journal-title":"Journal of Nippon Medical School"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-020-0612-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-020-0612-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-020-0612-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T19:22:16Z","timestamp":1612380136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-020-0612-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1007\/s11940-020-0612-z","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"5 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Andrea Galbiati declares that she has no conflict of interest. Dr. Francesca Casoni declares that she has no conflict of interest. Dr. Maria Salsone declares that she has no conflict of interest. Dr. Luigi Ferini-Strambi reports personal fees from UCB Pharma, personal fees from Lundbeck, personal fees from Pfizer, personal fees from Italfarmaco, personal fees from Valeas, personal fees from Angelini, personal fees from Eisai, and personal fees from Philips Respironics outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"4"}}